Published in J Neurol on November 07, 2014
BAG3: a new player in the heart failure paradigm. Heart Fail Rev (2015) 0.98
A comprehensive review of amyotrophic lateral sclerosis. Surg Neurol Int (2015) 0.93
Recent advances in amyotrophic lateral sclerosis. J Neurol (2016) 0.79
Rules for scoring respiratory events in sleep: update of the 2007 AASM Manual for the Scoring of Sleep and Associated Events. Deliberations of the Sleep Apnea Definitions Task Force of the American Academy of Sleep Medicine. J Clin Sleep Med (2012) 8.68
ATS/ERS Statement on respiratory muscle testing. Am J Respir Crit Care Med (2002) 5.24
Effects of non-invasive ventilation on survival and quality of life in patients with amyotrophic lateral sclerosis: a randomised controlled trial. Lancet Neurol (2006) 4.17
The kinase domain of titin controls muscle gene expression and protein turnover. Science (2005) 3.68
A randomized study of alglucosidase alfa in late-onset Pompe's disease. N Engl J Med (2010) 3.05
Titin mutation segregates with hereditary myopathy with early respiratory failure. Brain (2012) 3.02
Cross-reactive immunologic material status affects treatment outcomes in Pompe disease infants. Mol Genet Metab (2010) 2.99
The natural course of non-classic Pompe's disease; a review of 225 published cases. J Neurol (2005) 2.39
Prognostic factors for the late onset Pompe disease with enzyme replacement therapy: from our experience of 4 cases including an autopsy case. Mol Genet Metab (2010) 2.23
Disorders of the respiratory muscles. Am J Respir Crit Care Med (2003) 2.19
Mutation in BAG3 causes severe dominant childhood muscular dystrophy. Ann Neurol (2009) 2.03
Obesity hypoventilation syndrome: prevalence and predictors in patients with obstructive sleep apnea. Sleep Breath (2007) 1.98
Hereditary myopathy with early respiratory failure associated with a mutation in A-band titin. Brain (2012) 1.92
Choline acetyltransferase mutations cause myasthenic syndrome associated with episodic apnea in humans. Proc Natl Acad Sci U S A (2001) 1.90
Myofibrillar myopathy caused by novel dominant negative alpha B-crystallin mutations. Ann Neurol (2003) 1.77
Sleep and breathing in neuromuscular disease. Eur Respir J (2002) 1.72
The phenotype of limb-girdle muscular dystrophy type 2I. Neurology (2003) 1.70
Chronic respiratory care for neuromuscular diseases in adults. Eur Respir J (2009) 1.66
Titin founder mutation is a common cause of myofibrillar myopathy with early respiratory failure. J Neurol Neurosurg Psychiatry (2013) 1.64
Nemaline myopathy: a clinical study of 143 cases. Ann Neurol (2001) 1.57
Unexplained exertional limitation: characterization of patients with a mitochondrial myopathy. Am J Respir Crit Care Med (2001) 1.56
HIV-associated nemaline rod myopathy: role of intravenous immunoglobulin therapy in two persons with HIV/AIDS. AIDS Read (2008) 1.55
Hereditary myopathy with early respiratory failure: occurrence in various populations. J Neurol Neurosurg Psychiatry (2013) 1.52
An X-linked myopathy with postural muscle atrophy and generalized hypertrophy, termed XMPMA, is caused by mutations in FHL1. Am J Hum Genet (2008) 1.49
Late onset Pompe disease: clinical and neurophysiological spectrum of 38 patients including long-term follow-up in 18 patients. Neuromuscul Disord (2007) 1.46
Myofibrillar myopathies. Neuromuscul Disord (2011) 1.45
Phenotypic spectrum associated with mutations in the fukutin-related protein gene. Ann Neurol (2003) 1.44
Pompe disease: a neuromuscular disease with respiratory muscle involvement. Respir Med (2009) 1.41
Adult-onset nemaline myopathy presenting as respiratory failure. Respir Care (2008) 1.40
Mutations in TPM3 are a common cause of congenital fiber type disproportion. Ann Neurol (2008) 1.39
Lysosomal storage diseases: diagnostic confirmation and management of presymptomatic individuals. Genet Med (2011) 1.34
High antibody titer in an adult with Pompe disease affects treatment with alglucosidase alfa. Mol Genet Metab (2010) 1.32
Sporadic late onset nemaline myopathy. Neurology (2005) 1.32
Abnormal RNA processing associated with a novel tRNA mutation in mitochondrial DNA. A potential disease mechanism. J Biol Chem (1993) 1.31
Scapuloperoneal syndrome type Kaeser and a wide phenotypic spectrum of adult-onset, dominant myopathies are associated with the desmin mutation R350P. Brain (2007) 1.26
Clinical and morphological phenotype of the filamin myopathy: a study of 31 German patients. Brain (2007) 1.25
Modification of the natural history of adult-onset acid maltase deficiency by nutrition and exercise therapy. Muscle Nerve (2007) 1.20
Cardiac and respiratory failure in limb-girdle muscular dystrophy 2I. Ann Neurol (2004) 1.20
Protean phenotypic features of the A3243G mitochondrial DNA mutation. Arch Neurol (2009) 1.15
Evaluation of cardiac and respiratory involvement in sarcoglycanopathies. Neuromuscul Disord (2001) 1.14
Four and a half LIM protein 1 gene mutations cause four distinct human myopathies: a comprehensive review of the clinical, histological and pathological features. Neuromuscul Disord (2011) 1.14
Diagnostic criteria for late-onset (childhood and adult) Pompe disease. Muscle Nerve (2009) 1.12
Exome sequencing identifies a novel TTN mutation in a family with hereditary myopathy with early respiratory failure. J Hum Genet (2013) 1.08
Hereditary myopathy with early respiratory failure is caused by mutations in the titin FN3 119 domain. Brain (2013) 1.08
Exome sequencing identifies titin mutations causing hereditary myopathy with early respiratory failure (HMERF) in families of diverse ethnic origins. BMC Neurol (2013) 1.07
A mutation in the alpha tropomyosin gene TPM3 associated with autosomal dominant nemaline myopathy NEM1. Nat Genet (1995) 1.05
Desmin integrates the three-dimensional mechanical properties of muscles. Am J Physiol Cell Physiol (2001) 1.04
A polysomnographic study of daytime sleepiness in myotonic dystrophy type 1. J Neurol Neurosurg Psychiatry (2009) 1.04
Respiratory failure as a first presentation of myasthenia gravis. Med Sci Monit (2004) 1.03
Mild phenotype of nemaline myopathy with sleep hypoventilation due to a mutation in the skeletal muscle alpha-actin (ACTA1) gene. Neuromuscul Disord (2001) 1.02
Progressive nemaline (rod) myopathy associated with HIV infection. N Engl J Med (1987) 1.02
Myasthenic syndrome due to defects in rapsyn: Clinical and molecular findings in 39 patients. Neurology (2009) 1.00
Pulmonary manifestations of the idiopathic inflammatory myopathies. Clin Chest Med (2010) 1.00
Recent advances in respiratory care for neuromuscular disease. Chest (2006) 0.99
Identification of a founder mutation in TPM3 in nemaline myopathy patients of Turkish origin. Eur J Hum Genet (2008) 0.99
Mutations of tropomyosin 3 (TPM3) are common and associated with type 1 myofiber hypotrophy in congenital fiber type disproportion. Hum Mutat (2010) 0.99
Clinical and myopathological evaluation of early- and late-onset subtypes of myofibrillar myopathy. Neuromuscul Disord (2011) 0.99
Sleep disorders in adult-onset myotonic dystrophy type 1: a controlled polysomnographic study. Eur J Neurol (2011) 0.98
Adult-onset glycogen storage disease type 2: clinico-pathological phenotype revisited. Neuropathol Appl Neurobiol (2007) 0.98
Diagnosis and treatment of mitochondrial myopathies. Ann Med (2011) 0.98
A novel point mutation in the mitochondrial tRNA(Leu)(UUR) gene in a family with mitochondrial myopathy. Ann Neurol (1992) 0.96
Clinical and molecular characterization of patients with limb-girdle muscular dystrophy type 2I. Arch Neurol (2005) 0.96
Daytime sleepiness and REM sleep characteristics in myotonic dystrophy: a case-control study. Sleep (2011) 0.96
Screening for Pompe disease using a rapid dried blood spot method: experience of a clinical diagnostic laboratory. Muscle Nerve (2009) 0.96
Recurrent respiratory insufficiency and depressed ventilatory drive complicating mitochondrial myopathies. Neurology (1990) 0.96
Opportunistic infections in polymyositis and dermatomyositis. Arthritis Rheum (2005) 0.95
Depressed ventilatory response in oculocraniosomatic neuromuscular disease. Neurology (1976) 0.95
Long-term observational, non-randomized study of enzyme replacement therapy in late-onset glycogenosis type II. J Inherit Metab Dis (2010) 0.95
Modafinil for the treatment of hypersomnia associated with myotonic muscular dystrophy in adults: a multicenter, prospective, randomized, double-blind, placebo-controlled, 4-week trial. Clin Ther (2009) 0.92
Neuromuscular disease and respiratory failure. Pract Neurol (2008) 0.91
Adult-onset nemaline myopathy: a case report and review of the literature. Arch Pathol Lab Med (1997) 0.89
Reversible severe myopathy of respiratory muscles due to adult-onset type III glycogenosis. Neuromuscul Disord (1999) 0.88
Multisystem disorder in late-onset chronic progressive external ophthalmoplegia. Can J Neurol Sci (2011) 0.88
Organ dysfunction and muscular disability in myotonic dystrophy type 1. Medicine (Baltimore) (2011) 0.87
Polymyositis presenting with respiratory failure. J Neurol Sci (1984) 0.87
Respiratory failure revealing mitochondrial myopathy in adults. Chest (1992) 0.87
Reducing bodies and myofibrillar myopathy features in FHL1 muscular dystrophy. Neurology (2011) 0.86
Clinical variability in distal spinal muscular atrophy type 1 (DSMA1): determination of steady-state IGHMBP2 protein levels in five patients with infantile and juvenile disease. J Mol Med (Berl) (2008) 0.86
Daytime sleep in myotonic dystrophy is not caused by sleep apnoea. J Neurol Neurosurg Psychiatry (1994) 0.86
Assessment of ventilatory function in patients with neuromuscular disease. Clin Chest Med (1994) 0.86
A TPM3 mutation causing cap myopathy. Neuromuscul Disord (2009) 0.85
ALS with respiratory onset: clinical features and effects of non-invasive ventilation on the prognosis. Amyotroph Lateral Scler (2010) 0.85
The angiotensin-converting enzyme insertion/deletion polymorphism modifies the clinical outcome in patients with Pompe disease. Genet Med (2010) 0.84
Autosomal recessive oculopharyngodistal myopathy: a distinct phenotypical, histological, and genetic entity. J Neurol Neurosurg Psychiatry (2004) 0.84
Respiratory failure in Lambert-Eaton myasthenic syndrome. Chest (1987) 0.83
Respiratory patterns during sleep in mitochondrial myopathies with ophthalmoplegia. Eur Neurol (1991) 0.83
Oculopharyngodistal myopathy is a distinct entity: clinical and genetic features of 47 patients. Neurology (2011) 0.83
Congenital fibre type disproportion associated with mutations in the tropomyosin 3 (TPM3) gene mimicking congenital myasthenia. Neuromuscul Disord (2010) 0.83
Nature and frequency of respiratory involvement in chronic progressive external ophthalmoplegia. J Neurol (2011) 0.83
Domiciliary-assisted ventilation in patients with myotonic dystrophy. Chest (2002) 0.82
A novel mitochondrial tRNA(Phe) mutation inhibiting anticodon stem formation associated with a muscle disease. Biochem Biophys Res Commun (1998) 0.82
Diaphragmatic dysfunction in patients with idiopathic inflammatory myopathies. Neuromuscul Disord (2005) 0.82
Excessive daytime sleepiness in myotonic dystrophy. J Neurol Sci (1999) 0.82
Pulmonary function and electromyographic study of respiratory muscles in myotonic dystrophy. Muscle Nerve (1985) 0.82
Phenotypic heterogeneity in British patients with a founder mutation in the FHL1 gene. Eur J Hum Genet (2011) 0.82
Altered muscle force and stiffness of skeletal muscles in alpha-sarcoglycan-deficient mice. Am J Physiol Cell Physiol (2003) 0.82
Inclusion body myositis as a cause of respiratory failure. Chest (1993) 0.82
Mitochondrial myopathy with predominant respiratory dysfunction in a patient with A3243G mutation in the mitochondrial tRNA(Leu(UUR))gene. J Formos Med Assoc (1998) 0.81
Metabolic myopathies discovered during investigations of statin myopathy. Can J Neurol Sci (2008) 0.80
Sleep apnea in adult myotonic dystrophy patients who have no excessive daytime sleepiness. Sleep Breath (2009) 0.80
Prevalence of mitochondrial DNA disease in adults. Ann Neurol (2008) 4.72
Effects of non-invasive ventilation on survival and quality of life in patients with amyotrophic lateral sclerosis: a randomised controlled trial. Lancet Neurol (2006) 4.17
Mitochondrial DNA mutations in human colonic crypt stem cells. J Clin Invest (2003) 3.84
Pronuclear transfer in human embryos to prevent transmission of mitochondrial DNA disease. Nature (2010) 3.73
Mitochondrial optic neuropathies - disease mechanisms and therapeutic strategies. Prog Retin Eye Res (2010) 3.58
Pathogenic mitochondrial DNA mutations are common in the general population. Am J Hum Genet (2008) 3.56
A randomized placebo-controlled trial of idebenone in Leber's hereditary optic neuropathy. Brain (2011) 3.48
Dissection of the genetics of Parkinson's disease identifies an additional association 5' of SNCA and multiple associated haplotypes at 17q21. Hum Mol Genet (2010) 3.34
Phenotypic spectrum associated with mutations of the mitochondrial polymerase gamma gene. Brain (2006) 3.16
Exome sequencing identifies GATA-2 mutation as the cause of dendritic cell, monocyte, B and NK lymphoid deficiency. Blood (2011) 3.16
Titin mutation segregates with hereditary myopathy with early respiratory failure. Brain (2012) 3.02
Detection and quantification of mitochondrial DNA deletions in individual cells by real-time PCR. Nucleic Acids Res (2002) 2.88
A reduction of mitochondrial DNA molecules during embryogenesis explains the rapid segregation of genotypes. Nat Genet (2008) 2.82
What causes mitochondrial DNA deletions in human cells? Nat Genet (2008) 2.70
The epidemiology of mitochondrial disorders--past, present and future. Biochim Biophys Acta (2004) 2.41
Clinical expression of Leber hereditary optic neuropathy is affected by the mitochondrial DNA-haplogroup background. Am J Hum Genet (2007) 2.40
Universal heteroplasmy of human mitochondrial DNA. Hum Mol Genet (2012) 2.39
Prevalence of genetic muscle disease in Northern England: in-depth analysis of a muscle clinic population. Brain (2009) 2.38
A multicenter study of glucocerebrosidase mutations in dementia with Lewy bodies. JAMA Neurol (2013) 2.32
Single-cell expression profiling of dopaminergic neurons combined with association analysis identifies pyridoxal kinase as Parkinson's disease gene. Ann Neurol (2009) 2.21
Respiratory health and disease in Europe: the new European Lung White Book. Eur Respir J (2013) 2.12
The Gly2019Ser mutation in LRRK2 is not fully penetrant in familial Parkinson's disease: the GenePD study. BMC Med (2008) 2.10
Efficient mitochondrial biogenesis drives incomplete penetrance in Leber's hereditary optic neuropathy. Brain (2013) 2.08
Mitochondrial DNA polymerase-gamma and human disease. Hum Mol Genet (2006) 2.04
Mutant POLG2 disrupts DNA polymerase gamma subunits and causes progressive external ophthalmoplegia. Am J Hum Genet (2006) 1.99
Tau and alpha-synuclein in susceptibility to, and dementia in, Parkinson's disease. Ann Neurol (2007) 1.95
Influence of heterozygosity for parkin mutation on onset age in familial Parkinson disease: the GenePD study. Arch Neurol (2006) 1.94
Treatment for mitochondrial disorders. Cochrane Database Syst Rev (2012) 1.94
Variation in germline mtDNA heteroplasmy is determined prenatally but modified during subsequent transmission. Nat Genet (2012) 1.94
Mitochondrial aging is accelerated by anti-retroviral therapy through the clonal expansion of mtDNA mutations. Nat Genet (2011) 1.92
Mitochondrial DNA and survival after sepsis: a prospective study. Lancet (2005) 1.85
Prevalence of nuclear and mitochondrial DNA mutations related to adult mitochondrial disease. Ann Neurol (2015) 1.75
Titin founder mutation is a common cause of myofibrillar myopathy with early respiratory failure. J Neurol Neurosurg Psychiatry (2013) 1.64
Prominent sensorimotor neuropathy due to SACS mutations revealed by whole-exome sequencing. Arch Neurol (2012) 1.63
Mitochondrial DNA haplogroup cluster UKJT reduces the risk of PD. Ann Neurol (2005) 1.62
Mitochondrial donation--how many women could benefit? N Engl J Med (2015) 1.61
Characterizing mild cognitive impairment in incident Parkinson disease: the ICICLE-PD study. Neurology (2013) 1.53
Identification of an X-chromosomal locus and haplotype modulating the phenotype of a mitochondrial DNA disorder. Am J Hum Genet (2005) 1.50
The power to detect disease associations with mitochondrial DNA haplogroups. Am J Hum Genet (2006) 1.49
Mutations in the SPG7 gene cause chronic progressive external ophthalmoplegia through disordered mitochondrial DNA maintenance. Brain (2014) 1.49
Adult-onset spinocerebellar ataxia syndromes due to MTATP6 mutations. J Neurol Neurosurg Psychiatry (2012) 1.46
Human liver stem cells originate from the canals of Hering. Hepatology (2009) 1.46
Allelic variation of a functional polymorphism in the serotonin transporter gene and depression in Parkinson's disease. Parkinsonism Relat Disord (2006) 1.43
Huntington CAG repeat size does not modify onset age in familial Parkinson's disease: the GenePD study. Mov Disord (2008) 1.41
The prevalence and natural history of dominant optic atrophy due to OPA1 mutations. Ophthalmology (2010) 1.39
Two direct repeats cause most human mtDNA deletions. Trends Genet (2004) 1.39
Depletion of mitochondrial DNA in leucocytes harbouring the 3243A->G mtDNA mutation. J Med Genet (2006) 1.34
Spastic paraplegia gene 7 in patients with spasticity and/or optic neuropathy. Brain (2012) 1.34
Selection against pathogenic mtDNA mutations in a stem cell population leads to the loss of the 3243A-->G mutation in blood. Am J Hum Genet (2008) 1.32
Can mitochondrial DNA mutations cause sperm dysfunction? Mol Hum Reprod (2002) 1.32
Nuclear factors involved in mitochondrial translation cause a subgroup of combined respiratory chain deficiency. Brain (2010) 1.28
New treatments for mitochondrial disease-no time to drop our standards. Nat Rev Neurol (2013) 1.26
Locating the stem cell niche and tracing hepatocyte lineages in human liver. Hepatology (2009) 1.25
Dissociation of duration-based and beat-based auditory timing in cerebellar degeneration. Proc Natl Acad Sci U S A (2010) 1.25
Genotypes from patients indicate no paternal mitochondrial DNA contribution. Ann Neurol (2003) 1.23
Altered 2-thiouridylation impairs mitochondrial translation in reversible infantile respiratory chain deficiency. Hum Mol Genet (2013) 1.23
Noninvasive diagnosis of the 3243A > G mitochondrial DNA mutation using urinary epithelial cells. Eur J Hum Genet (2004) 1.22
Non-invasive ventilation in motor neuron disease: an update of current UK practice. J Neurol Neurosurg Psychiatry (2011) 1.22
OPA1 mutations cause cytochrome c oxidase deficiency due to loss of wild-type mtDNA molecules. Hum Mol Genet (2010) 1.22
The distribution of mitochondrial DNA heteroplasmy due to random genetic drift. Am J Hum Genet (2008) 1.22
Quality of life in patients with leber hereditary optic neuropathy. Invest Ophthalmol Vis Sci (2009) 1.21
The implications of mitochondrial DNA copy number regulation during embryogenesis. Mitochondrion (2011) 1.21
Adult-onset cerebellar ataxia due to mutations in CABC1/ADCK3. J Neurol Neurosurg Psychiatry (2011) 1.19
CYP7B1 mutations in pure and complex forms of hereditary spastic paraplegia type 5. Brain (2009) 1.18
Fall in circulating mononuclear cell mitochondrial DNA content in human sepsis. Intensive Care Med (2010) 1.17
OPA1 links human mitochondrial genome maintenance to mtDNA replication and distribution. Genome Res (2010) 1.17
Leber hereditary optic neuropathy presenting in a 75-year-old man. J Neuroophthalmol (2008) 1.17
Charcot-Marie-Tooth disease in Northern England. J Neurol Neurosurg Psychiatry (2011) 1.15
Systematic review and UK-based study of PARK2 (parkin), PINK1, PARK7 (DJ-1) and LRRK2 in early-onset Parkinson's disease. Mov Disord (2012) 1.14
Lifecourse predictors of adult respiratory function: results from the Newcastle Thousand Families Study. Thorax (2008) 1.13
Mutation of the linker region of the polymerase gamma-1 (POLG1) gene associated with progressive external ophthalmoplegia and Parkinsonism. Arch Neurol (2007) 1.13
Molecular epidemiology of spinocerebellar ataxia type 6. Ann Neurol (2004) 1.12
Evolutionary diversification of mitochondrial proteomes: implications for human disease. Trends Genet (2003) 1.11
Previous estimates of mitochondrial DNA mutation level variance did not account for sampling error: comparing the mtDNA genetic bottleneck in mice and humans. Am J Hum Genet (2010) 1.10
Molecular basis of infantile reversible cytochrome c oxidase deficiency myopathy. Brain (2009) 1.10
Polymerase γ gene POLG determines the risk of sodium valproate-induced liver toxicity. Hepatology (2010) 1.08
mtDNA mutations and common neurodegenerative disorders. Trends Genet (2005) 1.07
Preventing the transmission of pathogenic mitochondrial DNA mutations: Can we achieve long-term benefits from germ-line gene transfer? Hum Reprod (2013) 1.07
ANO10 mutations cause ataxia and coenzyme Q₁₀ deficiency. J Neurol (2014) 1.07
Detecting new neurodegenerative disease genes: does phenotype accuracy limit the horizon? Trends Genet (2009) 1.07
A model of the nuclear control of mitochondrial DNA replication. J Theor Biol (2003) 1.07
Welander distal myopathy is caused by a mutation in the RNA-binding protein TIA1. Ann Neurol (2013) 1.07
Clinical features and natural history of neuroferritinopathy caused by the 458dupA FTL mutation. Brain (2008) 1.06
SGCE mutations cause psychiatric disorders: clinical and genetic characterization. Brain (2013) 1.05
Normal levels of wild-type mitochondrial DNA maintain cytochrome c oxidase activity for two pathogenic mitochondrial DNA mutations but not for m.3243A-->G. Am J Hum Genet (2007) 1.05
Childhood presentation of "adult" polyglucosan body disease: normal GBE1 sequence with no glycogen branching enzyme activity. Ann Neurol (2013) 1.05
A methodological approach to tracing cell lineage in human epithelial tissues. Stem Cells (2009) 1.04
What is influencing the phenotype of the common homozygous polymerase-γ mutation p.Ala467Thr? Brain (2012) 1.01
Late-onset ptosis and myopathy in a patient with a heterozygous insertion in POLG2. J Neurol (2010) 1.01
A new phenotype of brain iron accumulation with dystonia, optic atrophy, and peripheral neuropathy. Mov Disord (2012) 1.01
Two-stage association study and meta-analysis of mitochondrial DNA variants in Parkinson disease. Neurology (2013) 1.00
Clinical differentiation of genetically proven benign hereditary chorea and myoclonus-dystonia. Mov Disord (2007) 0.99
Reply: Hereditary myopathy with early respiratory failure is caused by mutations in the titin FN3 119 domain. Brain (2013) 0.98
A novel ANT1 gene mutation with probable germline mosaicism in autosomal dominant progressive external ophthalmoplegia. Neuromuscul Disord (2005) 0.98
Diagnosis and treatment of mitochondrial myopathies. Ann Med (2011) 0.98
In-frame deletion in the seventh immunoglobulin-like repeat of filamin C in a family with myofibrillar myopathy. Eur J Hum Genet (2008) 0.97
In vitro supplementation with dAMP/dGMP leads to partial restoration of mtDNA levels in mitochondrial depletion syndromes. Hum Mol Genet (2009) 0.97
Familial myopathy: new insights into the T14709C mitochondrial tRNA mutation. Ann Neurol (2004) 0.96
Fatigue in primary biliary cirrhosis is associated with excessive daytime somnolence. Hepatology (2006) 0.96